Skip to main content
SpringerLink
Log in

Risk of liver and kidney toxicity, hypersensitivity reactions with antisense oligonucleotides

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Alhamadani F, et al. Adverse Drug Reactions and Toxicity of the FDA-approved Antisense Oligonucleotide Drugs. Drug Metabolism and Disposition : 20 Feb 2022. Available from: URL: https://doi.org/10.1124/dmd.121.000418

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Risk of liver and kidney toxicity, hypersensitivity reactions with antisense oligonucleotides. Reactions Weekly 1896, 11 (2022). https://doi.org/10.1007/s40278-022-10802-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-10802-x

Search

Navigation